Arthur J. Gallagher's second quarter arrived with the company in the middle of the largest bet in its history: buying AssuredPartners for roughly $14 billion and folding the biggest U.S. mid-market insurance distribution platform into its own brokerage engine. The deal closed in August 2025, and the second quarter was the first clean look at the scale it brings - and the first quarter in which the accounting fog of two mega-acquisitions no longer had a year-ago financing windfall to hide behind. There are two ways to read the print. The first is a disappointment dressed in GAAP: earnings per share fell from $1.40 to $1.25. The second is the quarter: revenue before reimbursements rose about 24% to $3.955 billion, adjusted earnings per share climbed roughly 24% to $2.84, and the combined brokerage and risk-management businesses grew organically by 6% - with risk-management fees up 12% organically. The first look is amortization and transaction costs doing arithmetic; the second is the operating business.
This matters because the earnings-per-share line this quarter is where acquisitions get priced in, not where they get earned out. Reported net earnings dropped to $324 million from $368 million, yet adjusted net earnings rose to $734 million from $604 million - a roughly 22% gain. The gap is acquisition amortization (which swelled to $301 million in the quarter), integration and transaction costs, and the comparison to a year-ago quarter that carried roughly $144 million of one-time interest income earned on AssuredPartners financing cash. The intensity of the divergence is the story: Gallagher is now running about $23 billion of goodwill and $10 billion of amortizable intangibles on its balance sheet, and the reported numbers will lag the economics until that amortization decays.
The test, and the tension, is whether the premium the market charges Gallagher can be earned. The stock rallied into the quarter, then sold off roughly 5% on the print and trades near $253 - about 19% below its 52-week high of $313.55 - even as the company grew adjusted earnings strongly. The market is not disputing the growth; it is asking whether roughly 18x forward earnings for a company still absorbing its largest-ever acquisition, with organic growth of 6% that must eventually stand on its own as AssuredPartners' acquisition revenue rolls off the base, is a fair price or a full one. Management was unambiguously upbeat - strong client retention, outstanding new business, robust demand in a complex risk environment - and pointed at the two-pronged growth strategy of organic compounding plus disciplined M&A. The question this quarter answers is whether the deal is working; the question the next few quarters answer is whether the growth pays for the multiple.